Stay updated on Daratumumab Combo in Severe Renal Impairment Clinical Trial

Sign up to get notified when there's something new on the Daratumumab Combo in Severe Renal Impairment Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Daratumumab Combo in Severe Renal Impairment Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The clinical trial record for the study of daratumumab, bortezomib, and dexamethasone in people with relapsed multiple myeloma and severe renal impairment is now accessible, with its study details and participant information displayed.
    Difference
    48%
    Check dated 2026-11-07T13:16:16.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.2 to v3.8.0 while the page continued to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T14:00:42.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    A site-wide NIH announcement appears above the page, linking to transition updates and describing a change in terminology from “Artificial Intelligence” to “Super Intelligence.”
    Difference
    1%
    Check dated 2026-10-24T16:20:44.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changed from v3.7.1 to v3.7.2 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-17T16:10:47.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The site footer revision identifier changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-10T16:11:46.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the previous study record content. This indicates access is blocked, with the error page and site footer shown instead of the study details.
    Difference
    18%
    Check dated 2026-09-19T20:35:47.000Z thumbnail image

Stay in the know with updates to Daratumumab Combo in Severe Renal Impairment Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Daratumumab Combo in Severe Renal Impairment Clinical Trial page.